Abirami Kumaresan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abirami Kumaresan has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Susan Cheng
Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California
2 shared publicationsTao Shen
Department of Anesthesiology, Cedars-Sinai Medical Center, Los Angeles, California
2 shared publicationsAmeeka Pannu
Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
1 shared publicationAndre Fiche Gosling
Department of Anesthesiology and Perioperative Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL
1 shared publicationAndres De Lima
Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
1 shared publicationAriel Ma Mueller
Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
1 shared publication
Latest Publications
- Open Access
- 16 June 2026
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 8 (6) , e1434
Non clinic-Based Interventions to Mitigate Post-Intensive Care Syndrome: A Scoping Review
OBJECTIVES: Survivors of critical illness and their caregivers often experience a complex constellation of sequelae in the aftermath of their recovery, termed post-intensive care syndrome (PICS) and PICS-Family (PICS-F), respectively. These can have a dire impact on patients and families, and thus require coordinated rehabilitative efforts. However, optimal modes of providing support services remain unclear, with traditional clinic-based strategies showing mixed results. This scoping review aimed to summarize the feasibility and effectiveness of nonclinic-based follow-up and rehabilitation strategies for adult survivors of critical illness and their caregivers. DATA SOURCES: Databases were searched on July 8, 2025, and included Cochrane, Embase, PubMed, and Web of Science. STUDY SELECTION: Studies reporting interventions and follow-up options for adult survivors of critical illness requiring ICU stay and targeting PICS and PICS-F were included. Studies examining interventions in the outpatient clinic or ICU settings exclusively were excluded. DATA EXTRACTION: Two team members used Covidence to screen all the deduplicated citations, with a third team member acting as a tiebreaker. The studies included were reviewed in full to extract general data, the studied syndrome (PICS, PICS-F, or both), component of PICS studied, study population, study objectives, methods, inclusion and exclusion criteria, intervention details, general results, and study conclusions. DATA SYNTHESIS: We screened 8608 studies; 45 studies met criteria and were included in this review. Most (64%) focused on the physical and psychological sequelae of PICS. Interventions varied widely, by setting, duration, and approach. Outcome measures were heterogeneous, limiting comparisons. Most studies evaluated the feasibility of interventions and not effectiveness. Only six articles targeted PICS-F exclusively. CONCLUSIONS: This scoping review summarizes the status of different nonclinic-based follow-up and rehabilitation strategies for adult ICU survivors. Future research focused on studies that evaluate effectiveness of these strategies in mitigating the burden of PICS and PICS-F, especially within the cognitive domain, is likely to improve aftercare for both patients and their families.
- 16 June 2026
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 8 (6) , e1434
Open AccessNon clinic-Based Interventions to Mitigate Post-Intensive Care Syndrome: A Scoping Review
OBJECTIVES: Survivors of critical illness and their caregivers often experience a complex constellation of sequelae in the aftermath of their recovery, termed post-intensive care syndrome (PICS) and PICS-Family (PICS-F), respectively. These can have a dire impact on patients and families, and thus require coordinated rehabilitative efforts. However, optimal modes of providing support services remain unclear, with traditional clinic-based strategies showing mixed results. This scoping review aimed to summarize the feasibility and effectiveness of nonclinic-based follow-up and rehabilitation strategies for adult survivors of critical illness and their caregivers. DATA SOURCES: Databases were searched on July 8, 2025, and included Cochrane, Embase, PubMed, and Web of Science. STUDY SELECTION: Studies reporting interventions and follow-up options for adult survivors of critical illness requiring ICU stay and targeting PICS and PICS-F were included. Studies examining interventions in the outpatient clinic or ICU settings exclusively were excluded. DATA EXTRACTION: Two team members used Covidence to screen all the deduplicated citations, with a third team member acting as a tiebreaker. The studies included were reviewed in full to extract general data, the studied syndrome (PICS, PICS-F, or both), component of PICS studied, study population, study objectives, methods, inclusion and exclusion criteria, intervention details, general results, and study conclusions. DATA SYNTHESIS: We screened 8608 studies; 45 studies met criteria and were included in this review. Most (64%) focused on the physical and psychological sequelae of PICS. Interventions varied widely, by setting, duration, and approach. Outcome measures were heterogeneous, limiting comparisons. Most studies evaluated the feasibility of interventions and not effectiveness. Only six articles targeted PICS-F exclusively. CONCLUSIONS: This scoping review summarizes the status of different nonclinic-based follow-up and rehabilitation strategies for adult ICU survivors. Future research focused on studies that evaluate effectiveness of these strategies in mitigating the burden of PICS and PICS-F, especially within the cognitive domain, is likely to improve aftercare for both patients and their families.
- 1 May 2025
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 140 (5) , 1239-1241
Preoperative Nutritional Risk Associations with Postoperative Morbidity and Mortality Following Elective Cardiac Surgery
- 1 May 2025
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 140 (5) , 1239-1241
Preoperative Nutritional Risk Associations with Postoperative Morbidity and Mortality Following Elective Cardiac Surgery
- 29 October 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 117 (6) , 1229
What Is the Oxygen Level? Challenges of Contemporary Oxygen Monitoring and Management in Extracorporeal Membrane Oxygenation
- 29 October 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 117 (6) , 1229
What Is the Oxygen Level? Challenges of Contemporary Oxygen Monitoring and Management in Extracorporeal Membrane Oxygenation
- 16 March 2023
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 51 (7) , e140-e144
Outcomes of Extremely Prolonged (> 50 d) Venovenous Extracorporeal Membrane Oxygenation Support
Objectives: There has been a sustained increase in the utilization of venovenous extracorporeal membrane oxygenation (ECMO) over the last decade, further exacerbated by the COVID-19 pandemic. We set out to describe our institutional experience with extremely prolonged (> 50 d) venovenous ECMO support for recovery or bridge to lung transplant candidacy in patients with acute respiratory failure. Design: Retrospective cohort study. Setting: A large tertiary urban care center. Patients: Patients 18 years or older receiving venovenous ECMO support for greater than 50 days, with initial cannulation between January 2018 and January 2022. Interventions: None. Measurements and Main Results: One hundred thirty patients were placed on venovenous ECMO during the study period. Of these, 12 received prolonged (> 50 d) venovenous ECMO support. Eleven patients (92%) suffered from adult respiratory distress syndrome (ARDS) secondary to COVID-19, while one patient with prior bilateral lung transplant suffered from ARDS secondary to bacterial pneumonia. The median age of patients was 39 years (interquartile range [IQR], 35–51 yr). The median duration of venovenous ECMO support was 94 days (IQR, 70–128 d), with a maximum of 180 days. Median time from intubation to cannulation was 5 days (IQR, 2–14 d). Nine patients (75%) were successfully mobilized while on venovenous ECMO support. Successful weaning of venovenous ECMO support occurred in eight patients (67%); 6 (50%) were bridged to lung transplantation and 2 (17%) were bridged to recovery. Of those successfully weaned, seven patients (88%) were discharged from the hospital. All seven patients discharged from the hospital were alive 6 months post-decannulation; 83% (5/6) with sufficient follow-up time were alive 1-year after decannulation. Conclusions: Our experience suggests that extremely prolonged venovenous ECMO support to allow native lung recovery or optimization for lung transplantation may be a feasible strategy in select critically ill patients, further supporting the expanded utilization of venovenous ECMO for refractory respiratory failure.
- 16 March 2023
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 51 (7) , e140-e144
Outcomes of Extremely Prolonged (> 50 d) Venovenous Extracorporeal Membrane Oxygenation Support
Objectives: There has been a sustained increase in the utilization of venovenous extracorporeal membrane oxygenation (ECMO) over the last decade, further exacerbated by the COVID-19 pandemic. We set out to describe our institutional experience with extremely prolonged (> 50 d) venovenous ECMO support for recovery or bridge to lung transplant candidacy in patients with acute respiratory failure. Design: Retrospective cohort study. Setting: A large tertiary urban care center. Patients: Patients 18 years or older receiving venovenous ECMO support for greater than 50 days, with initial cannulation between January 2018 and January 2022. Interventions: None. Measurements and Main Results: One hundred thirty patients were placed on venovenous ECMO during the study period. Of these, 12 received prolonged (> 50 d) venovenous ECMO support. Eleven patients (92%) suffered from adult respiratory distress syndrome (ARDS) secondary to COVID-19, while one patient with prior bilateral lung transplant suffered from ARDS secondary to bacterial pneumonia. The median age of patients was 39 years (interquartile range [IQR], 35–51 yr). The median duration of venovenous ECMO support was 94 days (IQR, 70–128 d), with a maximum of 180 days. Median time from intubation to cannulation was 5 days (IQR, 2–14 d). Nine patients (75%) were successfully mobilized while on venovenous ECMO support. Successful weaning of venovenous ECMO support occurred in eight patients (67%); 6 (50%) were bridged to lung transplantation and 2 (17%) were bridged to recovery. Of those successfully weaned, seven patients (88%) were discharged from the hospital. All seven patients discharged from the hospital were alive 6 months post-decannulation; 83% (5/6) with sufficient follow-up time were alive 1-year after decannulation. Conclusions: Our experience suggests that extremely prolonged venovenous ECMO support to allow native lung recovery or optimization for lung transplantation may be a feasible strategy in select critically ill patients, further supporting the expanded utilization of venovenous ECMO for refractory respiratory failure.
- 12 February 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 115 (5) , 1295-1296
If Intraoperative Transesophageal Echocardiography Impacts Outcomes, Why Is Use So Variable?
- 12 February 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 115 (5) , 1295-1296
If Intraoperative Transesophageal Echocardiography Impacts Outcomes, Why Is Use So Variable?
- Open Access
- 18 November 2022
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 4 (11) , e0804
Echocardiographic Evidence of Cardiac Atrophy in the Critically Ill
OBJECTIVES: The purpose of this explorative study is to determine if critically ill patients experience cardiac atrophy that can be quantified as a loss of left ventricular mass (LVM) and thus detected by echocardiography. DESIGN: Retrospective single-center cohort study. SETTING: Patients admitted to a tertiary medical center in Boston, MA. PATIENTS: Adult critically ill patients with ICU length of stay greater than or equal to 5 days. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We conducted a retrospective cohort study of 68 patients, of which 42 were included in the final analysis (mean age 60.9 ± 19.2 yr; 47.6% male). The median length of ICU stay was 11.3 days (interquartile range, 6.8–20.1 d). A decrease in mean LVM over the course of admission for critical illness was observed (median 189.11 g [162.82–240.20 g] vs 176.69 g [142.37–226.26 g]; p = 0.01). After adjusting for sex, age, fluid balance, ICU type, dietary orders, time between echocardiograms, and vasopressor use, this decrease in LVM remained consistent (mean difference, –21.30 g; 95% CI, –41.85 to –0.74; p = 0.04). Relative wall thickness (RWT) did not change during admission. CONCLUSIONS: These data reveal that a loss of LVM is present in patients over their ICU stay without a corresponding change in RWT, consistent with cardiac atrophy. Future prospective studies are needed to confirm these findings and identify possible sequelae of this finding.
- 18 November 2022
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 4 (11) , e0804
Open AccessEchocardiographic Evidence of Cardiac Atrophy in the Critically Ill
OBJECTIVES: The purpose of this explorative study is to determine if critically ill patients experience cardiac atrophy that can be quantified as a loss of left ventricular mass (LVM) and thus detected by echocardiography. DESIGN: Retrospective single-center cohort study. SETTING: Patients admitted to a tertiary medical center in Boston, MA. PATIENTS: Adult critically ill patients with ICU length of stay greater than or equal to 5 days. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We conducted a retrospective cohort study of 68 patients, of which 42 were included in the final analysis (mean age 60.9 ± 19.2 yr; 47.6% male). The median length of ICU stay was 11.3 days (interquartile range, 6.8–20.1 d). A decrease in mean LVM over the course of admission for critical illness was observed (median 189.11 g [162.82–240.20 g] vs 176.69 g [142.37–226.26 g]; p = 0.01). After adjusting for sex, age, fluid balance, ICU type, dietary orders, time between echocardiograms, and vasopressor use, this decrease in LVM remained consistent (mean difference, –21.30 g; 95% CI, –41.85 to –0.74; p = 0.04). Relative wall thickness (RWT) did not change during admission. CONCLUSIONS: These data reveal that a loss of LVM is present in patients over their ICU stay without a corresponding change in RWT, consistent with cardiac atrophy. Future prospective studies are needed to confirm these findings and identify possible sequelae of this finding.